<- Go Home
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. develops and commercializes vaccines. It offers investigational live virus vaccine, which is delivered as a nasal mist for the prevention of influenza. The company was formerly known as Aviron, Inc. and changed its name to MedImmune Vaccines, Inc. in January, 2002. The company was incorporated in 1996 and is based in Mountain View, California. As of January 15, 2002, MedImmune Vaccines, Inc. operates as a subsidiary of MedImmune, LLC.
Market Cap
$1.6B
Volume
684.9K
Cash and Equivalents
$156.6M
EBITDA
-$86.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$33.8M
Profit Margin
100.00%
52 Week High
$64.36
52 Week Low
$18.95
Dividend
N/A
Price / Book Value
5.42
Price / Earnings
-14.00
Price / Tangible Book Value
6.38
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$103.0M
Return on Equity
63.51%
Return on Assets
-17.92
Cash and Short Term Investments
$409.3M
Debt
$231.5M
Equity
$286.3M
Revenue
$33.8M
Unlevered FCF
-$79.1M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium